» Chapman-Amgen Oncology Medical Affairs Fellowship

The fellowship program, a collaboration between Chapman University School of Pharmacy (CUSP) and Amgen Inc., is designed to provide comprehensive training and experience in a broad range of Medical Affairs activities, with a focus on hematology-oncology disease areas.

The Outcome Goals of this 2-year fellowship will prepare the fellow to:

  • Actively participate in specific areas of medical affairs, clinical practice, and academia through intensive, hands-on training and mentorship at these settings
  • Gain experience in various areas of Medical Affairs, including Medical Communications, Medical Information, Medical Strategy, and other areas of industry
  • Promote the role and value of a clinically-trained pharmacist in Medical Affairs within the pharmaceutical industry
  • Become a highly competent candidate to be recruited by the pharmaceutical industry with expertise in hematology-oncology disease areas and medical affairs

The first 6 months will be comprised of clinical training and inter-professional experiences, which will be delivered through clinical rotations in two oncology practices to understand real-time oncology patient care and prepare the fellow for medical affairs rotations/activities. The fellow will engage in clinical topic discussions at the university and participate in the CUSP Teaching Certificate Program. Additionally, training of this nature will help develop the fellow in areas such as leadership, presentation organization/delivery, communication, biostatistics, pharmacoeconomics, pharmacogenomics, and more. The fellow will spend the remainder year and a half at Amgen in Thousand Oaks, California, actively participating in specific areas of medical affairs, such as medical information and medical communication, through intensive, hands-on projects with different teams.

Program Directors

Sun (Coco) Yang, BsPharm, M. Sci., PhD, BCPPS, APH
Assistant Professor, Department of Pharmacy Practice
Chapman University School of Pharmacy

Laila Khoury-Chamoun, PharmD
Executive Director, Oncology Global Medical Communications
Amgen Inc.


Toggle Section